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Abstract: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the “Coronavirus
Disease of 2019 (COVID-19)”, and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms
by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors –e.g. age, sex, race-,
the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the
progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly
on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of
COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible
changes can be implemented are the other questions, which are sought to be answered.
Key words: Angiotensin-converting enzyme 2 (ACE2), host genetics, polymorphisms, SARS-CoV-2, toll-like receptors (TLR),
transmembrane serine protease 2 (TMPRSS2)

1. Introduction
The novel severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), the zoonotic pathogen that causes
the “Coronavirus Disease of 2019 (COVID-19)”, and
COVID-19 itself is yet to be thoroughly understood. Both

the disease as well as the mechanisms by which the host
interacts with the SARS-CoV-2 infection have not been
fully enlightened.
An important feature of the host is its genetic structure.
Although genetic is a vast area of biological sciences, one
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object of interest can be identified regarding the medical
implications of this field: polymorphisms. Polymorphism,
which is described as the occurrence of a variation in the
genomic sequence where the infrequent variant is present
in 1% of the people being tested1, is one of the centerpieces
of genetic research. There is an innumerable amount
of research regarding this topic, e.g. the studies on the
effects of protein polymorphisms on the susceptibility to
SARS. To expand this exemplary subject of SARS research,
polymorphic variants of host proteins such as dendritic
cell-specific intercellular adhesion molecule-3-grabbing
non-integrin (DC-SIGN) (Chan et al., 2010), intracellular
adhesion molecule 3 (ICAM-3) (Ka et al., 2009),
angiotensin converting enzyme 2 (ACE2) (Chiu et al.,
2004) and tumor necrosis factor α (TNF-α) (S. Wang et al.,
2008), and their roles in the SARS infections were heavily
studied after the SARS-CoV outbreak in 2002. Along
the lines of these articles, several studies regarding the
polymorphisms of the viral genome were also conducted.
For example, Shang et al. searched for polymorphisms in
116 genomes of SARS-CoV and compared the BJ202 and
GZ02 genomes (Shang et al., 2006). Considering the fact
that SARS-CoV and SARS-CoV-2 share 79.5% of each
other’s DNA (Suryamohan et al., 2021), one can question
the role of host and virus genetics in the SARS-CoV-2
infection and COVID-19, just the same as the questions
that were raised in the times of the SARS outbreak.
Similar to SARS and the Middle Eastern Respiratory
Syndrome (MERS), COVID-19 presents with dry cough,
fever, ground glass opacities on chest computerized
tomography (CT) scans and dyspnea (Huang et al., 2020).
Another similarity is that SARS-CoV-2 and its namesake
SARS-CoV both use the ACE2 protein for entering the host
cells (Ge et al., 2013; Hoffmann, Kleine-Weber, Krueger et
al., 2020). Since these symptoms and the viruses’ cell entry
mechanisms are associated with the respiratory system,
environmental and personal factors, e.g., smoking, diet
ary habits, which affect this system, are other areas of
COVID-19 that need to be clarified. However, in studies
focusing on the genetic affinity between SARS-CoV and
SARS-CoV-2, it should be noted that clinical data differ
between SARS-CoV and SARS-CoV-2 due to the fact that
there are variations between the rates of infection, virulence,
and transmission of these two viruses (Rossi et al., 2020).
In addition, serious data sources were created for SARSCoV-2, various biological databases are currently in use
to search both proteins and the genome of SARS-CoV-2,
which holds geographical and phylogenetic data of variants
and mutants of this virus. Since there are a lot of data for
SARS-CoV-2 compared to SARS-CoV, the differences
between the genetic analysis approaches for SARS-CoV
NHGRI (2020). Talking Glossary of Genetic Terms, Polymorphism [online].
Website: www.genome.gov/genetics-glossary/Polymorphism [accessed 4
November 2020].
1

and SARS-CoV-2 should be taken into account when
evaluating polymorphic variants. For instance, https://
grasp.nhlbi.nih.gov/Covid19GWASResults.aspx provides
many genomewide association analysis (GWAS) data for
immediate use in COVID-19. Even if the association of
the infection with respiratory failure is poorly understood,
higher mortality is widely linked to older age and the male
sex (Li et al., 2020; F. Zhou et al., 2020). Hypertension,
diabetes, and other obesity-related and cardiovascular
disease traits have also been found in association with the
infection. However, the relative role of clinical risk factors
in determining the severity of COVID-19 has not yet been
clarified. Hence, GWAS association analysis (GWAS) may
be a crucial tool in identifying genetic factors involved
in the development of the infection (R. Chen et al., 2020;
Docherty et al., 2020; “Genomewide Association Study of
Severe Covid-19 with Respiratory Failure,” 2020; Q. Li et
al., 2020; S et al., 2020; F. Zhou et al., 2020).
We asked the abovementioned questions with the aim
to answer them in the occasion of this study. We focused
mainly on the effect of polymorphic variants of the host
proteins that have been shown to take part in and/or
affect the pathogenesis of COVID-19. Additionally, how
the procedures of diagnosing and treating COVID-19 are
affected by these variants and what possible changes can
be implemented are the other questions, which are sought
to be answered.
2. Angiotensin converting enzyme 2 (ACE2)
ACE2 was first identified as the angiotensin converting
enzyme (ACE) homologous, which has zinc
metalloproteinase activity. It is now known that it has
numerous activities different from those of the ACE
(Burrell et al., 2012). It is a major regulator in cardiac
function (Burrell et al., 2012) and it was also discovered
to be a functional receptor of SARS-CoV (Ge et al., 2013).
While the spike (S) protein of MERS-CoV uses
dipeptidyl peptidase-4 (DPP4) as the attachment molecule,
S protein of SARS-CoV and SARS-CoV-2 tend to use the
human ACE2 as their main receptor (F. Li, 2015; R. Yan et
al., 2020). This means that SARS-CoV-2 uses the ACE2
membrane protein to enter the cell with a high efficiency
and infect the organism (Corley & Ndhlovu, 2020; Wan et
al., 2020). It is stated that SARS-CoV-2 S proteins show
more affinity towards ACE2 than SARS-CoV does, and
this may have made SARS-CoV-2 more contagious than
SARS-CoV (Chakraborty, 2021; Delgado et al., 2021;
Suryamohan et al., 2021; Wrapp et al., 2020). However,
this statement opposes the conclusion that was drawn by
other researchers, which argue that the affinities of SARSCoV-2 and SARS-CoV to ACE2 are similar (Lan et al.,
2020; Walls et al., 2020). In addition, twenty natural ACE2
variants identified can positively affect the susceptibility
of the virus by changing the interaction between the virus
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and the host, and play an important role in this situation
(Suryamohan et al., 2021). In addition, 20 natural ACE2
variants identified can positively affect the susceptibility
of the virus by changing the interaction between the virus
and the host and play an important role here (Suryamohan
et al., 2021).
Overall, the ACE2 population variants that increase or
decrease sensitivity have been reported to be rare, and this
rarity has been reported to be consistent with the overall
low appearance of the ACE2 receptor polymorphisms. But
it is paramount to associate the ACE2 genotypes and the
clinical pictures in a population-wide manner in order
to understand the importance of the ACE2 variations
in susceptibility for such infections (Suryamohan et al.,
2021).
2.1. ACE2 variants and spike proteins
When the interaction between the human ACE2 variants
and the SARS-CoV-2 S proteins are investigated, using
homology modeling and superimposition methods, which
focused on whether the ACE2 variants have a potential
effect on the susceptibility to the infection, 3 alleles of 17
variants that were included in recent research were found
to affect the attachment stability. The variants attached
almost the same way, topologically. This is not surprising
when it is considered that there are no significant
differences between the backbones of these variants
(Hussain et al., 2020). No pathogenic results were found
regarding to these alleles (Hussain et al., 2020). Via the
superimposition method, different variants were observed
on the 6LZG complex (Johansson et al., 2012).
The binding affinity is higher between SARS-CoV-2
and ACE2 compared to that between SARS-CoV and
ACE2 (Gheblawi et al.,2020). The binding between ACE2
and the S protein of the SARS-CoV-2 are instinctively high
to stabilize this connection at the whole-virus level (Yang et
al.,2020). In addition, mutations of SARS-CoV-2 also have
differences in binding affinity to ACE2, for example, the
N501Y mutant is known to have greater binding affinity
compared to other mutant types (Ali et al., 2021). This
difference is not only between SARS-CoV-2 mutants and
human ACE2, but also at the interaction of SARS-CoV-2
with ACE2 in terms of other organisms: the binding
capacity of the human ACE2 proteins with SARS-CoV-2
is relative to mammals that are genetically close - such as
mice and rats- is higher (Indu et al., 2020). The difference
between the mutant types’ affinities for binding to ACE2
causes the virus variants, including mutations, to interact
with the ACE2 protein at a different rate, for instance,
the B.1.1.7 and B.1.351 variants are more advantageous
compared to other variants in terms of binding affinity
with ACE2 (Ramanathan et al., 2021). Compared to the
viruses that are closely related to SARS-CoV-2, such as
NL63, SARS-CoV, the advantage of the ACE2 binding
of SARS-CoV-2 can be explained by reasons such as
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hydrophobic cluster formation and importance of binding
site residues (Rawat et al.,2021). Considering this situation
of high binding affinity between SARS-CoV-2 and ACE2
in the receptor-binding domain (RBD) axis, although the
SARS-CoV RBD is in a more compact form compared
to the SARS-CoV-2, some residual changes in the SARSCoV-2 RBD seem to affect the interaction of the SARSCoV-2 RBD and ACE2, which is known to stabilize the
SARS-CoV-2 RBD and ACE2 interface (Shang et al.,
2020b).
2.2. Non-Human ACE2 Polymorphisms
When we focus on the ACE2 polymorphisms in different
species, according to the genome sequencing analysis
results pursued by Suryamohan et al., (2021), the virus
shares the closest similarity, up to 96.2%, with “bat-CoV
RATG13” (Suryamohan et al., 2021). Similarities between
SARS-CoV-2 and SARS-CoV are found to be around
79.5%. According to such data, an assumption can be
made that the virus originates from bats, and, for a reason
still unknown, it has been carried to humans with another
intermediary (Suryamohan et al., 2021), possibly through
a pangolin (Lam et al., 2020) (Figure 1). Some additional
evidence is found, however, when the interaction of the
different S proteins of the different coronaviruses and the
different host ACE2s are observed via in silico studies; it
is said that the receptor binding domain (RBD) of SARSCoV-2 obtained its interface segment via the complex
evolutionary processes rather than a mutation buildup.
When several CoV S protein RBDs, including bat CoVs and
other suspected intermediate host CoVs like the pangolin
and palm civet, were investigated, crucial modifications
in the SARS-CoV-2 infection of humans were observed
(Xia et al., 2020; R. Yan et al., 2020). Besides, by examining
eight different variants at the interaction surface of ACE2,
it was found that none of these variants would impair
the interaction with the viral RBD of SARS-CoV-2. In
RBD multi-sequencing analyses, it was observed that the
interface segment of SARS-CoV-2 shows more similarity
with RatG13, SZ16, ZS-C, WIV16, 101 MA15, and SARSCoV-Sino1-11 isolates rather than the Rm1, the Bat-SLCoVZC45, and 98 Bat-SL-CoVZXC21 isolate (Othman
et al., 2020). Antony and Vijayan (2021) have suggested
that we may come across genetic variations in ACE2,
which could affect the expression level as well as protein
conformation and stability, which can also alter the SARSCoV-2 S protein affinity. Accordingly, this may cause
humans to be more resistant or susceptible (Antony &
Vijayan, 2021).
2.3. Individual differences and their impact on ACE2
2.3.1. Sex
There is a consistency with the finding that the conversion
of Angiotensin (Ang) II to Ang 1-7 by ACE2 is higher
in males than in females, suggesting an over-expression
of ACE2 in males, although there are some studies
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Figure 1. The possible origin of SARS-CoV-2 and its similarities: An illustration showing the genomic similarities shared
by SARS-CoV-2, SARS-CoV and bat-CoV RaTg13. The illustration also displays the disputed origin of the SARS-CoV-2:
the bat and/or the pangolin (Lam et al., 2020; Othman et al., 2020).

claiming that there is no correlation between sex and
ACE2 expression (Chen et al., 2020; Devaux et al., 2020;
Gibson et al., 2020). Zhao et al., (2020), mentioned that
the ACE2 expression profiles in normal lung cells in Asian
males have a higher expression of ACE2 compared to the
Caucasian and African populations (Zhao et al., 2020).
There are scientists who have come to the conclusion
that if the sex effect on mortality was considered, some
connections may be deemed possible between the higher
death ratio in males caused by SARS and MERS and the
ACE2 X-linked inheritance (Darbani, 2020; W. Gibson et
al., 2020; Q. Li et al., 2020). Additionally, pregnancy, sex
chromosomes, estrogen signalling, and the ACE2 receptor

levels are also proposed to be advantageous factors in
females when compared to male (Stelzig et al., 2020). The
fact that the human ACE2 protein is encoded on the X
chromosome means that the males who carry rare ACE2
variants will express those variants in all ACE2-expressing
cells, while females will typically express those variants in
a mosaic distribution determined by early X-inactivation
events (Gibson et al., 2020). Since ACE2 is X-linked, the
rare variants that enhance SARS-CoV-2 binding in vivo
would likely increase susceptibility to COVID-19 in males
(Gibson et al., 2020). The X chromosome inactivation of the
female body causes a “mosaic pattern”, meaning that half of
the cells have the paternal X chromosome inactivated, and
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the other half has the maternal chromosome inactivated.
This mosaicism may be in the advantage of the female
host in terms of local inflammation and viral interaction
(Gemmati et al., 2020). Other functional effects are also
possible; as an example, the female variant carriers might
have a shorter asymptomatic duration, or be more likely
to develop symptoms, regardless of the viral shedding
status (Gibson et al., 2020). Moreover, due to the X-linked
phenotype, interaction booster and inhibitor ACE2
variants, which have been discovered by Darbani (2020),
tend to being expressed more often in males rather than
in females (Darbani, 2020). The effect of ACE2 becomes
stronger via protease enzymes (cathepsin B (CTSB),
cathepsin L (CTSL), type II transmembrane serine protease
(TMPRSS2) that are determined by autosomal heredity
because there is no difference between the sex dependent
expressions of ACE2 variants in asexual tissues (Darbani,
2020). However, a study done on male and female rats
showed that there is a sex difference in basal ACE2 activity
selectively in the kidneys. The reported difference states
that ACE2 in female kidneys are lower due to the hormonal
effects of the ovaries mainly related to estradiol (Liu et al.,
2010). These contradicting statements underlie the fact
that this question of sex-based susceptibility via ACE2
needs to be thoroughly investigated. Ultimately, SARSCoV-2 can affect males and females equally; however, the
prognosis might be worse in males (M. Y. Li et al., 2020; Q.
Li et al., 2020) (Figure 2).

2.3.2. Ethnicity
The fact that China is the birthplace of both the SARS
and COVID-19 pandemics has raised some questions
regarding the idea that maybe Asians are somehow more
susceptible to these coronaviruses. According to Devaux
et al., (2020), Asian people have higher ACE2 levels than
the Caucasian and African-American populations. Asian
people have higher ACE2 levels than the Caucasian and
African-American populations. (Devaux et al., 2020)
However, it was discovered by Chen et al. (2020), that
the Asians are not different from other populations in
terms of ACE2 expressions (Ying Chen et al., 2020). The
controversy, hence, continues.
Studies focusing on ethnicity were continued by Li
et al., (2020), by investigating the Asian and Caucasian
populations in respect to ACE2 polymorphisms. They
examined whether there is a variety between ACE2
expressions in the peripheral blood of 8 different
populations, to discover genetic polymorphisms and
variations in expressions of ACE2 (Q. Li et al., 2020). They
also observed the ACE2 variations in terms of expression
levels. However, as the differences were not significant, it
could not be understood whether susceptibility would be
caused in different populations (M. Y. Li et al., 2020).
Moreover, Darbani (2020), pursued another research
using data from 4 human populations, including
Europeans, Asians, Africans and Americans (Darbani,
2020). Accordingly, there are population-specific and
non population-specific variants of ACE2. Some of the

Figure 2. Epidemiological status in Turkey (patients/deaths). Pie charts showing the sex distribution of the reported cases and reported
deaths in Turkey. Epidemiological data are taken from the “COVID-19 Weekly Situation Report (19 October 2020 – 25 October 2020)”
published by the Ministry of Health of Turkey.1 These distributions may help to assess both the sex and ethnicity-based differences in
prognosis.
Republic of Turkey Ministry of Health (2020). COVID-19 Weekly Situation Report 19/10/2020 – 25/10/2020 Turkey [online]. Website: https://
dosyamerkez.saglik.gov.tr/Eklenti/39230,covid-19-weekly-situation-report---43pdf.pdf?0&_tag1=D3D202441F1F5165A33D16981E6544EF7
FC0A32F [accessed 4 November 2020].
1
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discovered variants were acting as an interaction booster,
and these variants showed a some variation between
populations. Some of the variants showed inhibitory
characteristics, and these also showed some of the
variations across populations (Table 1). However, the
effect of the Asian specific variants to viral infectivity are
unclear (Darbani, 2020). Therefore, the Asian population
is not included in Table 1.
2.3.3. Age
ACE2 has a positive correlation with age on the middle aged
and elderly population, meaning that the susceptibility
increases with age (Ying Chen et al., 2020), although
SARS-CoV-2 can infect young and old people, equally. It
is also seen that when the ACE2 expression levels between
younger and older populations (≤49 years and >49
years, respectively) are compared, there is no statistically
significant difference between the groups in any tissue (M.
Li et al., 2020). From another perspective, O’Driscoll et
al., (2020), examined age-specific COVID-19-associated
death data from 45 countries. They found that the age
distribution of deaths in younger age groups less than 65
years is very consistent. However, when going to ages over
65 years, they observed heterogeneous infection fatality
patterns across countries (O’Driscoll et al., 2020).
2.3.4. Tissue types and ACE2
ACE2 is found in cardiomyocytes, cardiac fibroblasts,
pericytes, the vascular endothelium, and vascular smooth
cells (Bavishi et al., 2020; Bojkova et al., 2020). When it
comes to the ACE2 expression differences between tissues,
in a research where CD8(+) cells, interferons (IFNs) and
natural killer (NK) cells were used as indicators (M. Li et
al., 2020), it was found that although the inflammation
of the lungs is the primary symptom of patients with the
SARS-CoV-2 infection, the lungs had moderate expression
of ACE2 when compared with all the other tissues, and also
it was noticed that males have a higher ACE2 expression
in the lungs than females (Devaux et al., 2020) (Figure 3).
In TCGA datasets, ACE2 expression levels between
the Asian and non-Asian races in five normal tissues
(stomach, thyroid, breast, liver and pancreas) were also
compared, and any significant difference between the
races in any tissue was null (M. Y. Li et al., 2020). Likewise,
in the TCGA datasets, it was observed that the ACE2 was
not differentially expressed between males and females or
Table 1. Population based ACE2 variant
characteristics.
Interaction Booster Inhibitor
European H378R

-

African

M82I

S19P

American -

Q388L

between younger and older groups in any tissue (Figure 4)
(M. Y. Li et al., 2020). However, the aforementioned study
of Liu et al., (2010) has to be kept in mind when discussing
the asexual tissue distribution of ACE2 (Liu et al., 2010).
2.3.5. The cardiovascular system and ACE2
Cardiac injury in viral infections is often related to
the involvement of cardiomyocytes and systemic
inflammations (Bojkova et al., 2020). The downregulation
of ACE2 expression leads to diseases such as heart failure,
hypertension, and diabetes (Bavishi et al., 2020; T. Yan et
al., 2020).
As for the studies regarding the cardiovascular
system, single nucleotide polymorphism (SNP) research
was applied to five different populations. Although the
mentioned studies (Table 2) found no correlations, when
another study that investigated patients who have Diabetes
Mellitus type II (DM-II) was observed, it was found that
there is an association between the rs2285666-G and
rs2285666-A variants and septal thickness. The study also
states that the G8790A polymorphism of the ACE2 gene
plays a role in the pathogenesis of coronary artery disease
in patients with DM-II (M.Y. Li et al., 2020). Although
cardiogenic shock presents itself in low numbers,
in patients with the SARS-CoV-2 infection, cardiac
complications related to the underlying atherosclerotic
cardiovascular diseases may significantly increase the
severity of COVID-19 in vulnerable individuals (Bansal
2020; Hu et al., 2021).
2.3.6. ACE2, dna methylation and cytokines
Systemic lupus erythematosus (SLE) patients are
seemingly more susceptible to SARS-CoV-2 as the gene
expression in the T cells and in several tissues could be
modified (Renauer et al., 2015). DNA hypomethylation
and expressions of various genes may be higher in SLE
patients than in the normal population. This is because
the DNA methylase activity regulated by the ras- mitogenactivated protein kinase (MAPK) could be inhibited by
MAPK inhibition (Deng et al., 2001). For instance, an
abnormal inactivation for the normally inactivated X
chromosome causes T cell autoimmunity due to increased
CD40L expression in CD4(+) cells in women. As a starting
point of such, research on the ACE2 gene suggests that
female SLE patients have hypomethylation on the ACE2
promoter sites in their CD4(+) T cells (M. Zhao et al.,
2014). Therefore, the ACE2 mRNA transcription is higher
than normal. Especially in this situation, overexpression of
ACE2 that functions as a receptor for SARS-CoV-2 may
facilitate viral pathogenesis. Viral oxidative stress also can
trigger hypomethylation and viremia (Y. Li et al., 2014).
When the DNA methylation of the ACE2 loci in
various tissues was compared with using the raw genomewide DNA methylation array, DNA methylation was
measured to be maximal in the lungs and minimal in the
neurons and the leukocytes. However, it can be stated that
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Figure 3. ACE2 expression in lung tissues.

the DNA methylation might be affected by tissue type, age,
sex, and several other factors (Corley & Ndhlovu, 2020).
Another expected hypomethylation region in SLE are
the cytokine genes. Hypomethylation of the IFN synthesis
regulating genes and the nuclear factor kappa B (NF-κB)
pathway genes that regulate cytokine release may cause
an overtly strong immune response and cytokine storm
(Renauer et al., 2015). Especially, the hypomethylation
of cytokine genes in double-negative T cells that express
interleukin 17 (IL-17), IL-18 and IFN gamma (IFN-γ),
intensify the cytokine storm (Renauer et al., 2015).
3. Ace polymorphisms, in general
Polymorphism studies in countries that have a high
COVID-19 prevalence showed that the insertion allele of
the ACE deletion/insertion (D/I) polymorphism correlates
with COVID-19 prevalence although the ACE enzyme
has no direct impact on the SARS-CoV-2 pathogenesis.
However, the ACE D allele shows negative correlation
with COVID-19 prevalence. Controlled experimental
studies have suggested that the ACE polymorphisms also
affect the mortality rates in COVID-19 (Delanghe et al.,
2020). The decrease of ACE2 expression and the deletion
allele of ACE may cause the pulmonary disease to progress
as an increase of ACE2, and an alteration in the ACE
activity may be advantageous for the pulmonary disease
progression (Gemmati et al., 2020).
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4. Type II transmembrane serine protease (tmprss2)
Serine proteases of the trypsin-like family have been known
as critical effectors of biological transactions as various as
digestion, blood coagulation, fibrinolysis, and immunity
(Antalis et al., 2011). Research to date has indicated
that the androgen receptors are found in the respiratory
epithelium, especially in type 2 pneumocytes and the
bronchial epithelium, in humans and mice. However, the
TMPRSS2 expression increased two-fold when lung cells
were injected with androgen and TMPRSS2, known to
contain an androgen-sensitive enhancer region, was also
on the list of androgen target genes (Mikkonen et al., 2010)
(Figure 5).
TMPRSS2, which is highly expressed on the luminal side
of the prostate epithelium in cancerous cells, is found to be
in rather high levels in cancerous prostate cells compared
to non-cancerous cells (Lucas et al., 2008). TMPRSS2 is
a member of the ETS family of oncogenic transcription
factors, contributing to somatic gene rearrangements
most commonly involving ERG with TMPRSS2, common
to one of the most widely observed gene fusion events in
solid tumors (Stopsack et al., 2020). Hormonally regulated
TMPRSS2-ERG gene fusion prevalence is higher in
European males which have primary prostate cancer
(50%) in comparison with Asian or Black males. In males,
prostate tumors which have TMPRSS2-ERG gene fusion
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sex

Figure 4. ACE2 expression discrepancies. Population, sex and age discrepancies in
terms of ACE2 expressions in the thyroid, stomach, pancreas, breast and liver. With
the aforementioned tissues considered, no difference was found between the sexes,
between the young and elderly populations and between the Asian and non-Asian
populations.

also possess increased insulin/insulin dependent growth
factor levels (Pettersson et al., 2013).
TMPRSS2 also supports the virus’s entry into host
cells by proteolytically dissociating and activating viral
envelope glycoproteins. TMPRSS2 is essential for human
coronaviruses - including SARS-CoV-2 - and influenza
viruses to begin cell invasion and to reproduce.2 Hoffmann
et al., (2020) reported that the emerging SARS-CoV-2
infection depends on the host cell factors such as ACE2 and
TMPRSS2, and that TMPRSS2 exhibits a cumulative effect
with furin in the course of virus entry. This furin activation
facilitates entry of the virus into cell types that exhibit
particularly low TMPRSS2 expression. Consequently,
SARS-CoV-2 entry into the host cells is dependent on
ACE2, which acts as a receptor for the viral S glycoprotein,
and TMPRSS2, which provides a fusion of the host cellviral cell envelopes (Hoffmann, Kleine-Weber, Schroeder,
et al., 2020; Ou et al., 2020; J. Shang et al., 2020a; Walls et
2
NCBI (2021). Gene, TMPRSS2 transmembrane serine protease 2
[Homo sapiens (human)] [online]. https://www.ncbi.nlm.nih.gov/
gene?Db=gene&Cmd=ShowDetailView&TermToSearch=7113.
[accessed 11August 2020].

al., 2020; Zhou P. et al., 2020). There is a process utilized
by SARS-CoV-2 to enter the host cell, which is defined
as follows: the attachment to the cell using the (ACE2)
receptor followed by creating a viral S protein using
cellular TMPRSS2 (Hoffmann, Kleine-Weber, Schroeder,
et al., 2020).
Immunohistochemical analyses showed that TMPRSS2
expression on lung bronchial epithelial cells is higher than
that of the type II alveolar cells that produce the surfactant.
Furthermore, there is no TMPRSS2 expression on the type
I lung cells which are responsible for forming the lung
surface (Bertram et al., 2012). Apart from lung and prostate
cells, the protein of TMPRSS2 and TMPRSS2 mRNA
were also found overall in the human body (Bertram et
al., 2012; Lucas et al., 2008). These studies could explain
the non-respiratory symptoms caused by the presence of
coronaviruses and influenza viruses (Stopsack et al., 2020).
Stopsack et al., (2020) showed that the COVID-19 and
influenza incidences are higher in males. In addition, it
may be affected by the consumption of cigarettes and the
high incidence in males might be explained by the fact that
cigarette smokers are mostly male. TMPRSS2 expression
is controlled by androgens and seems like it explains high
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Table 2. Cardiovascular effects of ACE2 variants.
Association with CVP*
Females

Males

rs1978124 (MI**)
rs4646142 (MI**)
rs4646156 (LVM-ST***)
rs879922 (LVM-ST***)
rs4240157 (LVM-ST***)
rs233575 (LVM-ST***)
rs1978124 (ACSAM****)
rs2106809 (HCMP*****)
rs6632667 (HCMP*****)

No Association with
CVP*
rs2285666 (MI**)

rs2285666 (LVM-ST***)

Note: The rs228566 allele has been highly associated with the
risk of cardiovascular mortality in females, assuming the dose
-dependent effect on the ACE2 protein (Vangjeli et al., 2011).
In the analysis with regards to sex rs1978124 (1075A/G) and
rs4646142 (16854G/C) were found to be risky for females, and
it has been reported that females carrying the 1075AA and
16854GG genotypes are at higher risk in recessive models for
myocardial infarction (Yang et al., 2006). Left ventricle mass and
septal thickness of German males have a positive correlation
with the rs4646156, rs4240157, and rs233575. The rs2106809
and rs6632667 are connected with hypertrophic cardiomyopathy
in Chinese males. The rs2285666 A allele is connected with low
interventricular septal thickness and low left ventricular mass
(Vangjeli et al., 2011). The rs4240157, rs4646155 and rs48300542
variants could affect blood pressure and the rs2074192, rs233575
and rs2158083 variants are deemed pathological. The ACE I/D
and ACE2 G8790A alleles are shown to increase blood pressure
(Yongyue Chen & Yu, 2018; Pinheiro et al., 2019), which revealed
the connections between the rs2106809 and the decreasing of
blood pressure of patients who take ACE inhibitors. Female
hypertensive patients who have the CC:CT heterozygous allele,
have more blood pressure decrease than the TT homozygous
individuals (Yongyue Chen & Yu, 2018). *: CVP: cardiovascular
pathologies; **: MI: myocardial infarction; ***: LVM-ST: left
ventricle mass-septal thickness; ****: ACSAM: acute coronary
syndrome associated mortality; *****: HCMP: hypertrophic
cardiomyopathy.

male predominance. It is surprising that when the lung
tissue is analyzed for the TMPRSS2 protein and its mRNA,
there is no difference between both sexs (Stopsack et al.,
2020). However, in post-menopausal females, the estrogen
drop affected the TMPRSS2 expression, showing that the
gene is also estrogen-respondent (Gemmati et al., 2020).
All around the world, poor prognosis has been
associated with senility, comorbidities and the male sex.
Also, Asselta et al., (2020) showed that Italy has a high male
to female ratio of patients (male/female = 1.62) (Asselta et
al., 2020) like other concurrent studies. When the same
source was re-reviewed after 9 months (on 11 January
2021), it was seen that the ratio had changed (Figure 6).
Asselta et al., (2020) claimed that the high male to female
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ratio was also similar to that of the 2003 SARS and 2012
MERS outbreak (Asselta et al., 2020). However, the website
shows that the female patient numbers exceeding the
number of male patients. This issue should be investigated
in further detail in future studies, as there may be other
underlying reasons for the change in rates.
Nevertheless it has been said many times that
males are more prone to having greater severity and
mortality, independent of age (Jin et al., 2020). Such
male predominance can also be corroborated with
Baena et al., (2013)’s research about the relationship
between TMPRSS2 expression and with androgenic
and estrogenic stimulation, showing that TMPRSS2
expression is responsive to such stimulations (Baena et
al., 2013). However, the current information is insufficient
to reach a definitive conclusion about the effect of male
to female ratios. When age is considered, Asselta et al.,
(2020) confirmed that there was no significant difference
in the male to female ratio of TMPRSS2 levels among
different ages (Asselta et al., 2020). According to the study
of Schuler et al., (2021), the very low levels of TMPRSS2
expression in human infants suggest a mechanism by
which neonates may be relatively protected against severe
forms of COVID-19.
In addition, females have stronger immune response
to viral infections compared to males due to the more
vigorous nature of their humoral and cellular immune
responses (Klein & Flanagan, 2016). Compensating effects
should not be overlooked in postmenopausal females as
a result of low estrogen or in females receiving hormone
replacement therapy (Asselta et al., 2020).
Asselta et al., (2020), in addition to sex ratio, searched
for TMPRSS2 gene variations between ethnicities (Table
3). They reported that the number of deleterious variants
in Italians was significant lower compared to other
Europeans, and that Italians may have higher TMPRSS2
protein/activity, which may contribute to a worse prognosis
in the Italian population. Yet, the East Asian population
has the lowest deleterious variants, so this decrease was
even more evident. However, the number of the Italian
population over 65 years of age is also twice as high as in
the Hubei region, which may also be a factor explaining
higher mortality rates as old age is a major risk factor for
mortality (Asselta et al., 2020; Jernigan & Cox, 2015).
A quantitative method was developed by OrtizFernández & Sawalha (2020) to cumulatively express
genetic variations in ACE2 and TMPRSS2 expressions,
and genetic differences among more than 2500 individuals
from five different regions of the world were investigated.
They explained that the East Asian populations
had the maximum values for genetic descriptors of
TMPRSS2 expression, while Africans showed a genetic
predisposition for the lowest TMPRSS2 expression levels
among populations and there was no difference between
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Figure 5. Human TMPRSS2 expression. Illustration showing the tissues
where TMPRSS2 is expressed. The human TMPRSS2 mRNA is expressed
in numerous tissues - including the prostate, breast, bile duct, kidney, colon,
small intestine, pancreas, ovary, salivary gland, stomach, and lung- more
often in epithelial cells.

Italian patients’ sex distribution

Females

Males

Figure 6. Epidemiological status in Italy (Patients).
A pie chart displaying the sex distribution of
patients in Italy. Constructed with the data from
Istituto Superiore di Sanità of Italy.1 Containing
discrepancies in comparison with the 9-month
earlier study of Asselta et al., (2020) (Asselta et al.,
2020). These distributions may help to assess both
the sex-based and ethnicity-based differences in
prognosis.
1
L’epidemiologia per la sanità pubblica, Istituto Superiore di
Sanità (2021) Dati della Sorveglianza integrata COVID-19
in Italia [online]. Website: https://www.epicentro.iss.it/
coronavirus/sars-cov-2-dashboard. [accessed 24 January
2021].

the male and female individuals in terms of TMPRSS2.
These results suggest that a genetic component could help
reduce reported cases of COVID-19 in Africa. However,
non-genetic factors such as age and comorbidities may
play a more important role than host genetic factors
in determining the severity and outcome of disease in
infected individuals (Ortiz-Fernández & Sawalha, 2020).
When frequently encountered exonic foci are
examined, four SNP frequencies show a distinct difference
in Italians and East Asians. Three out of four variants
that show change are point mutations that do not
ultimately cause a difference, while the other mutation is
a missense mutation; p.Val160Met (Asselta et al., 2020).
The p.Val160Met variant has recently been found to be
associated with a mutation in TMPRSS2, particularly
in terms of the risk of prostate cancer (FitzGerald et al.,
2008) and the examination of this variant in patients
may shorten the diagnosis time in high-risk individuals
(Giri et al., 2011). In addition to this information, in two
different cohort studies, they showed that high expressions
of TMPRSS2-related single-nucleotide polymorphisms
(SNPs) cause predisposition to the influenza virus (Z.
Cheng et al., 2015).
Actually this transmembrane protein, although it plays
a role in many pathways, does not have any essential duties
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Table 3. SNPs associated with the haplotypes from Asselta et al., (2020).
The SNPs which compose the “European Haplotype”

The SNPs that compose the “Other Haplotype”

rs463727, rs34624090, rs55964536, rs734056, rs4290734,
rs2070788, rs9974589, rs7364083
rs34783969, rs11702475, rs35899679, rs35041537
Note: Table showing the core SNPs associated with the “European haplotype” and the “other haplotype”
mentioned in Asselta et al., (2020). The “European haplotype”, which is not found in Asians and is thought
to increase the TMPRSS2 gene expression in an androgen-spesific way and the “other haplotype”, associated
with high TMPRSS2 levels. It has to be noted that rs2070788 is found to increase the risk both to human A
(H7N9) and severe A(H1N1)pdm09 influenza (Z. Cheng et al., 2015). An interesting point is that the ratio
of male patients to female patients in influenza A (H7N9) was found to be higher than 2 (Jernigan & Cox,
2015).

in the cell (Kim et al., 2006). So, it can be inhibited without
major complications in an effort to stop the spread of the
virus.
Hatesuer et al., (2013) studied TMPRSS2 in knock-out
mice. They found that, if the TMPRSS2 was knocked-out
in H1N1 infected mice, their infections were more modest
and attenuated than that of the control group; also the
mortality, loss of body mass and lung pathologies were
found to be lesser (Hatesuer et al., 2013). As TMPRSS2
activates the influenza virus by cleaving hemagglutinin,
this may suggest that the enzyme may contribute to virus
invasion of human airways (Chaipan et al., 2009).
5. The toll-like receptor (TLR) family
Toll-like receptors (TLRs) are a kind of pattern recognition
receptors (PRRs) (Newton & Dixit, 2012). PRRs, which
play a role in innate immunity, are activated by detecting
pathogen-associated molecular patterns (PAMPs) and
damage-associated molecular patterns (DAMPs), and
oligomerizes multi-subunit complexes and creates signals
that stimulate leukocytes. There are 10 TLRs (TLR1 TLR10) defined in humans. Besides; TLR11, TLR12, and
TLR13 defined in mice are included in the TLR family
(Lim & Staudt, 2013). They generate different immune
responses by stimulating signal pathways by detecting
molecules such as teichoic acid (TA), arabinogalactan,
lipopolysaccharide (LPS), unmethylated double-strand
DNA (CpG), 23S rRNA, single-strand RNA (ssRNA),
double-strand RNA (dsRNA) (Mahla et al., 2013). In our
current problem, the COVID-19 pandemic, it is of great
importance to investigate whether polymorphisms on
TLRs effect the course of the disease.
TLRs are expressed either on the cell membrane or the
intracellular membrane of endosomes (Figure 7). Human
endosomal TLRs (TLR 3, 7, 8, 9) mostly work to register the
viral infections by identifying various nucleic acids from
external sources (Fitzgerald & Kagan, 2020). The TLRs 7
and 8, which are endosomal receptors, detect viral nucleic
acid PAMPs by detecting ssRNA. (Totura & Baric, 2012).
TLR 8 can also detect RNAse T2 degradation products
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(Greulich et al., 2019). A meaningful insight into this
will be that the Coronaviruses are viruses with single and
positive stranded RNA ranging from 26-32 kb. (Perlman
& Netland, 2009). The main reason that TLRs 7 and 8 are
exceptions is that they are encoded in the X chromosome
(C. H. Wang et al., 2011), and dosage compensation for
X-linked gene products in women is achieved by random
silencing of one of the two X chromosomes during the
early development of female embryos therefore the
fact that TLR 7 escapes the silencing of one of the X
chromosomes in females makes this exception paramount
(Souyris et al., 2018). This means that in females, TLR7
is expressed with respect to the genetic material of both
of the X chromosomes. As this expression profile may
cause sex-based differences in immune responses, causing
females to have a more active response to single-stranded
viruses (de Groot & Bontrop, 2020), these differences have
to be thoroughly investigated. Another intriguing topic
of interest regarding TLRs 7 and 8 is that they play an
essential role in the pathogenesis in SLE, a disease more
prominent in females, and they exhibit polymorphisms in
the forms of copy number variations (CNV) and SNP (C.
M. Wang et al., 2014).
TLR3 recognizes double-stranded RNA (dsRNA)
motifs from invading pathogens and enables activation
of transcription factors. Although the role of TLR4 in
pathogenic coronavirus infections is unclear, both receptors
are sensitive in the pathogenesis of SARS-CoV and regulate
pathogenesis. In addition, showed that mice lacking TLR3
and TLR4 had increased weight loss, mortality, decreased
lung function, increased lung pathology, and higher viral
titers (Totura et al., 2015). The SARS-CoV NSP16 protein
shows 2-O’-methyltransferase activity and prevents the
detection of cytosolic RNA by MDA5, thus escaping the
immune system (Menachery et al., 2014). TIR domaincontaining adapter molecule 2 (TICAM2) is a TLR adapter
protein specific to TLR4. Increased susceptibility to SARSCoV pathogenesis in TICAM2 deficient mice has been
shown. The TLR4 signaling pathway plays a decisive role
in the pathogenesis of viral infections. Variations in genes
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Figure 7. TLR types and localizations. Illustration showing the endosomal
and cell surface toll-like receptor (TLR) types.

that affect this signal pathway can be determinative in
disease progression (Gralinski et al., 2017).
Structural changes on TLR2 and TLR4 due to
polymorphisms in the TLR genes have an effect that can
alter immune responses to some disease factors. Moreover,
SNPs on these TLRs exhibit ethnic variations. Some Asian
populations show high and low frequencies in comparison
with Africans and Caucasians (Leung et al., 2005).
6. CD14 polymporphisms
CD14-159TT carriers have higher sCD14 levels than
CD14-159CC carriers (Kabesch et al., 2004). The possible
role of these polymorphisms is to change the inflammatory
response in the individual. Although the mechanism of
CD14 in response to viruses is not fully known, CD14159CC polymorphism has been observed to show a higher
frequency in patients with SARS-CoV compared to CD14159TT. In line with these findings, it can be said that
antiviral activity may be decreased in patients carrying
CD14-159CC and may be characterized by a more severe
SARS-CoV infection (Yuan et al., 2007).
7. AB0 blood groups
Previous studies showed that AB0 blood systems could
affect the susceptibility of viral infections such as the
Norovirus (Liao et al., 2020) and the Hepatitis B virus
(Batool et al., 2017). Moreover, it was monitored that the A
and D (Rhesus) blood groups have an effect on the severity

of the West Nile virus prognosis (Kaidarova et al., 2016). It
was also reported that the O blood group individuals are
less infected by SARS-CoV virus (Y. Cheng et al., 2005).
Therefore, Zhao et al., (2020) figured the AB0 blood groups
could be a secondary biomarker for SARS-CoV-2 infection
(J. Zhao et al., 2020). In addition, when the SARS-CoV-2
+ individuals are compared to the general population, the
A blood group had increased risk while the O blood group
has shown lower risk than others (J. Zhao et al., 2020). Dai
(2020) explained the susceptibility of SARS-CoV-2 and
AB0 blood groups’ protective effect by implying that the
O blood groups have an effect on ACE and ACE2 levels
and indirectly changes IL-6 and C-Reactive Protein (CRP)
levels; meanwhile, the A blood group has a significant
effect on ICAM-1 and P-selectin levels (Dai, 2020).
There are some conflicts about whether the AB0 blood
group types affect the susceptibility to SARS-CoV-2 or the
severity of the disease. Although there are studies that have
reported that there is no correlation between susceptibility
and the AB0 blood group types, some studies indicate that
A and B blood group has a higher susceptibility for the
virus. And even if the O blood type had protective effects
on SARS-CoV, it was stated that people with the O blood
group were at lower risk (Wu et al., 2020). Sardu et al.,
(2020) and Tanigawa et Rivas (2020) stated that blood type
A has a significantly higher risk for COVID-19 compared
to those who are not of blood type A, but that blood type
O has a significantly lower risk for COVID-19 compared
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to those without blood type O. Although they have stated
that AB0 blood group may have a higher sensitivity to
COVID-19, more studies are needed (Sardu et al., 2020;
Tanigawa & Rivas, 2020). Also, Zietz et al., (2020) found
that the B blood group’s ratio was higher in COVID+
patients rather than COVID- individuals (Zietz et al.,
2020).
Likewise, there are also studies with conflicting
results regarding the correlation between the severity of
COVID-19 and the AB0 blood group types (Table 4). Some
studies indicate that there is no significant relationship
between the AB0 blood group types and the severity of the
disease (Dai, 2020; Mendy et al., 2020; Wu et al., 2020).
On the other hand, according to Zhao et al., (2020) the
mortality is higher in the A blood group , again, blood type
O has a lower risk and compared to AB0 blood types, AB
blood type and B blood group are prone to high risk (J.
Zhao et al., 2020). Further investigations are necessary to
shed light on such evidence.
8. Individual Discrepancies Related to Lifestyles and
Origins
8.1. Smoking
The fashion in which smoking effects COVID-19 and the
aftermath is still unknown. Early data have not ensured
enough proof on the connection between smoking and the
detrimental effects of COVID-19 (Lippi & Henry, 2020;
Vardavas & Nikitara, 2020). Comprehending these factors
is crucial for analyzing the clinical risk, evolving the
information about clear public health, and finding targets
for intervention. Prior and present smoking raise the
risk of viral (Abadom et al., 2016; Denholm et al., 2010)
and bacterial (Feldman & Anderson, 2013) respiratory
infections and they are associated with worse outcomes for
the ones who are infected. The fact that smoking decreases
respiratory immune protection along with the behavioral
attitudes of smoking may be a reason for intensified
transmission (Beamer et al., 2015).
It has been reported that smokers are 1.5 times
more likely to develop severe respiratory disease from
COVID-19 infection than non-smokers, and are
approximately 2.5 times more likely to be hospitalized
in intensive care units (Vardavas & Nikitara, 2020).
However, this has not been persistently reported (Lippi &
Henry, 2020). A review stated that the signs about disease
severity in patients who are hospitalized for COVID-19
is higher in prior/present smokers than those who had
never consumed tobacco before; nevertheless, there was
no sufficient evidence to come to a decision on infection,
hospitalization or mortality (Simons et al., 2020). A metaanalysis indicated that smoking is a risk factor for the
progression of COVID-19 disease due to its adverse effects
on pulmonary immune function, and that smokers have
an approximately 2 times higher probability of COVID-19
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Table 4. AB0 polymorphisms and ACE inhibitors.
AB0 blood group polymorphisms

rs495828, gene promoter
rs8176746, exon 7

Note: Select AB0 blood group polymorphisms that affect the
treatment response of ACE inhibitors (Gemmati et al., 2020).

progression than non-smokers (Patanavanich & Glantz,
2020).
When analyzed by self-report in a population sample,
present smoking was separately linked with a higher
probability of COVID-19 infection. Chances of contracting
COVID-19 were 3.5 times greater in present smokers
without post-16 qualifications than those who had never
smoked before after modification for covariates, but they
did not differ fundamentally by smoking status in patients
with post-16 qualifications. Socio-economic inequalities
were clearly found in those without post-16 qualifications.
Smokers stated lesser obedience to principles although
being more concerned than non-smokers about getting
infected and becoming critically ill due to COVID-19.
COVID-19 was also associated with gradual increase in
smoking frequency as a result of stress, especially with the
ones without post-16 qualifications (Jackson et al., 2020).
The population-based studies of Gaiha et al., (2020)
ensured that young users of e-cigarettes during youth
and binary users of e-cigarette and cigarettes are at higher
risk of COVID-19. Surprisingly, exclusive ever-use of
combustible cigarettes was found to be only correlated with
COVID-19 related testing, considering that former 30-day
use, ever-use of e-cigarettes and binary use were correlated
with COVID-19 testing and positive diagnosis (Gaiha
et al., 2020). There are some possible reasons why both
binary use and e-cigarette use were correlated with getting
infected with COVID-19: amplified exposure to nicotine
and alternative chemicals in e-cigarettes unfavorably
influences lung infection and it is clear that e-cigarettes
are just as harmful as tobacco cigarettes (Reinikovaite
et al., 2018), COVID-19 outspreads as a consequence of
recurrently touching of one’s hands to the mouth and face
(Berlin et al., 2020). Sharing equipment is again a common
implementation by the whole of youth e-cigarette users
(McKelvey & Halpern-Felsher, 2020).
In a recent study, there is clear controversy that
a population in the UK revealed smoking to be
unquestionably linked with higher COVID-19 mortality,
falling under age and sex; yet at the same time linking
smoking with a lessened risk for COVID-19 mortality
(Williamson et al., 2020). The defensive connection
maintained stable after a few separate adjustments to the
model. While smoking has several plausible biological
mechanisms and defense effects associated with the less
severe disease of COVID-19, it is improbable to weigh
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down the proven adverse effects of smoking. Obviously,
evidence about this topic is restricted and thus confusing;
more studies should be done and it should not be concluded
that smoking has a protective effect (Usman et al., 2020).
8.2. Obesity and diabetes
As factors such as blood groups, age, race, sex, and smoking
have an effect on COVID-19, body mass index (BMI) may
also be an important factor for COVID-19. Early research
revealed that obesity (having a BMI higher than 30) may
be a risk factor for patients younger than 60 years old
(Lighter et al., 2020). A cohort study of 489,796 adults
from UK Biobank attempted to reveal the relationship
between body mass index categories and central obesity
with COVID-19. According to the results of the study,
adults with high BMI had a greater dose-response increase
in the risk of severe COVID-19 than those with a normal
weight (Zhu et al., 2020).
Obese patients at the time of their hospitalization
had higher plasma CRP levels and lower lymphocyte
counts, which are considered as the two early indicators
of severe COVID-19. It has also been shown that patients
with obesity have a greater duration of hospital stay and a
more severe disease course (Gao et al., 2020). In addition
to these effects, it has been stated that fatty liver disease
caused by obesity increases the severity risk for COVID-19
six-fold. Moreover; the diet associated with obesity, which
consists mainly of fats, activates the innate immunity
while disrupting the adaptive immunity, which, in turn,
causes chronic inflammation and the vulnerability of the
host’s defense (Engin et al., 2020).
Diabetes patients are also among the groups with high
risk in the COVID-19 pandemic associated with obesity
(Acharya et al., 2020). COVID-19 patients without other
comorbidities but with diabetes have been shown to be at
risk of more severe pneumonia, release of tissue-damagerelated enzymes, excessive uncontrolled inflammatory
responses, and hypercoagulation due to dysregulation of
glucose metabolism. Serum levels of biomarkers such as
IL-6, CRP, D-dimer, and serum ferritin coagulation index
were significantly higher than those without diabetes. This
has shown that diabetes patients are more susceptible to
cytokine storm in COVID-19 infections (Guo et al., 2020).
8.3. Ethnicity
The hosts’ genetics may also take part in the disease
displayed as ethnicity. However, considering that ethnicity
may also be treated as a social topic in the modern
healthcare systems, looking at ethnicity from only a
genetic standpoint would cutback the observable effects it
has on the outcome of this disease.
From the genetics view point alone, the first thing that
can be noted is that there is a Neanderthal-derived risk
haplotype arising from chromosome 3, which presents
itself at a frequency of 30% in South Asia, 8% in Europe,

4% in mixed Americans. However, although this rate
rises to 63% in Bangladesh, the rate in Africa is almost
zero (Zeberg & Pääbo, 2020). Furthermore, Amodio et
al., (2021) deduce that the Neanderthal haplotype may
increase the severity of the disease. In order to confirm,
the risk of dying from the disease was compared in the
Bangladeshi population residing in the UK with the
general population (Amodio et al., 2021). The reason that
this haplotype is deemed as a “risk haplotype” is the fact
that the 3p21.31 gene cluster was identified as a genetic
susceptibility locus for patients with COVID-19 that have
respiratory failure by the “The Severe Covid-19 GWAS
Group” (2020) (“Genomewide Association Study of Severe
Covid-19 with Respiratory Failure,” 2020). Mortazavi et
al., (2021) also stated that the genetic disposition caused
by the Neanderthal heritage in the Iranian population may
play an increasing role in the course and the severity of the
disease in Iran (Mortazavi et al., 2021). However, Zeberg
and Pääbo (2021) concluded that a Neanderthal haplotype
on chromosome 12 containing the genes OAS1, OAS2 and
OAS3 play a protective role against the disease (Zeberg
& Pääbo, 2021). These haplotypes may contribute to the
individual differences in both the intra- (as individuals in
the same population may have different ancestries) and
inter-population level.
The fact that there is a non-uniform effect between
Black and Asian populations and that these ethnicities
are disproportionately more severely affected by this
disease has been clarified by several studies (Abedi et al.,
2020; Lassale et al., 2020; Raisi-Estabragh et al., 2020).
However, one study claimed that once hospitalized, the
Black population mortality rates were among the “norm”,
and there is minimal racial difference in the severity of
comorbidity or disease (Silver et al., 2020). This difference
shows how the socioeconomic status of the patients affect
the outcome of COVID-19. Both Lassale et al., (2020)
and Raisi-Estabragh et al., (2020) showed that lower
socioeconomic conditions experienced in minority ethnic
groups in the UK (i.e. Black, Asian and Other populations)
are associated with worse global health problem (Lassale
et al., 2020; Raisi-Estabragh et al., 2020). In addition and
as an example for how socioeconomic status can further
affect the disease is made visible by periodontal disease, it
is associated with lower socioeconomic status (AlmerichSilla et al., 2017) and it is thought to be associated with
COVID-19 infections (Kara et al., 2020).
However, the ethnicity based differences cannot be
adequately explained by socioeconomic factors only
(Raisi-Estabragh et al., 2020), and the associations
were attenuated when the socioeconomic factors were
considered (Lassale et al., 2020). Thus, there is a need for
this topic to be thoroughly explored. These discoveries
highlight the importance of acknowledging all the patient
traits including their ethnicities and socioeconomic status
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as they might show the need for extra preventive measures
to be taken.
9. Conclusion and future prospects
The epidemiological factors –e.g., age, sex, race, the
polymorphisms, the blood types, and individual
differences have all been in discussions about affecting the
progression and the course of COVID-19 both individually
and collectively, as their effects are mostly interwoven.
Likewise, it cannot be denied that the social parameters
impose sanctions on the disease too.
Personalized medicine is in the form of appropriate
medication at the right time, for the right patient,
according to the personal diagnosis. The medical history
of each patient and the prognosis of the disease are not one
and the treatment approach should be arranged according
to patient-specific parameters. In this pandemic we are
in, a consensus on the appropriate drug and appropriate
treatment approach for the SARS-CoV-2 infection has
yet to be reached. While determining the appropriate
treatment approach, parameters varying according to
individuals should be the primary focus and the correct
drug and treatment should be administered accordingly.
To achieve this ideal of personalized medicine, some
basic tests for determining the variants of the patients can
be done and a thorough anamnesis should be recorded.
Special drug regimens regarding the patient’s status and
characteristics can, thus, be given. Further research is
needed to further extend our knowledge about this disease
and to enhance the medical amenities that can be provided
to patients.
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